The company in July submitted its application to the U.S. Food and Drug Administration and in August closed on $750,000 in capital. This latest funding would be a catalyst to launch the technology.
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.